Short-term mortality and implementation of antiretroviral treatment for critically ill HIV-infected children in a developing country

Archives of Disease in Childhood

Volumn 92, Issue 3, 2007, Pages 234-241

  Cowburn, C ^a   Hatherill, M ^a   Eley, B ^a   Nuttall, J ^a   Hussey, G ^a   Reynolds, L ^a   Waggie, Z ^a   Vivian, L ^a   Argent, A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ANTIRETROVIRUS AGENT; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; CLOTRIMAZOLE; CLOXACILLIN; EFAVIRENZ; FLUCONAZOLE; GANCICLOVIR; GENTAMICIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMIPENEM; LOPINAVIR PLUS RITONAVIR; MEROPENEM; PIPTAZOBACTAM; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CRITICAL ILLNESS; DEVELOPING COUNTRY; GASTROENTERITIS; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MENINGITIS; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; SEPTIC SHOCK; SOUTH AFRICA; SURVIVAL RATE;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; DEVELOPING COUNTRIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; PROSPECTIVE STUDIES; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 33947245172     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.074856     Document Type: Article

References (27)

1. UNAIDS. Report on the global HIV/AIDS epidemic. Available at http://www.unaids.org (accessed October 2004).
2. Dunn DT, Newell ML, Ades AE, et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585-8.
3. Mofenson LM. Advances in the prevention of vertical transmission of human immunodeficiency virus. Sem Pediatr Infect Dis 2003;14:295-308.
4. Thome C, Newell ML. Prevention of mother-to-child transmission of HIV infection. Curr Opin Infect Dis 2004;17:247-52.
5. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda:HIVNET 012 randomised trial. Lancet 1999;354:795-802.
6. Zwi K, Pettifor J, Soderlund N, et al. HIV infection and in-hospital mortality at an academic hospital in South Africa. Arch Dis Child 2000;83:227-30.
7. Goulder PJR, Jeena P, Tudor-Williams G, et al. Paediatric HIV infection: correlates of protective immunity and global perspectives in prevention and management. British Med Bulletin 2001;58:89-108.
8. Cooper S, Lyall H, Walters S, et al. Children with human immunodeficiency virus admitted to a paediatric intensive care unit in the United Kingdom over a 10-year period. Intensive Care Med 2004;30:113-18.
9. Jeena PM, McNally LM, Stobie M, et al. Challenges in the provision of ICU services to HIV infected children in resource poor settings: a South African case study. J Med Ethics 2005;31:226-30.
10. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment programme for HIV infected children and their infected parents. S Afr Med J 2004;94:643-6.
11. Lyall EGH. Paediatric HIV in 2002 - a treatable and preventable infection. J Clin Virol 2002;25:107-19.
12. Saarland M, Gibb DM, Tudor-Williams G. Advances in the prevention and treatment of paediatric HIV infection in the United Kingdom. Arch Dis Child 2002;87:178-80.
13. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ 2003;327:1019.
14. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43:1-12.
15. Shann F, Pearson G, Slater A, et al. Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 1997;23:201-7.
16. Sharland M, Castelli G, Ramos JT, on behalf of the PENTA steering committee, et al. Penta Guidelines for the use of antiretroviral therapy in paediatric HIV infection 2001. Available at http://www.ctu.mrc.ac.uk/penta (accessed December 2006).
17. Van Rossum AM, Fraaij PL, de Groot R. Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis 2002;2:93-102.
18. Zar HJ, Apolles P, Argent A, et al. The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing country. Pediatr Crit Care Med 2001;2:108-12.
19. Wilfret C. Prevention of mother-to-child transmission of HIV: reflections on implementation of PMTCT in the developing world. Acta Paediatr 2002;91:863-5.
20. Jeena PM, Coovadia HM, Bhagwanjee S. Prospective controlled study of the outcome of human immunodeficiency virus-1 antibody-positive children admitted to an intensive care unit. Crit Care Med 1996;24:963-7.
21. Jeena PM, Wesley AG, Coovadia HM. Admission patterns and outcomes in a paediatric intensive care unit in South Africa over a 25-year period (1971-1995). Intensive Care Med 1999;25:88-94.
22. Morris A, Wachter RM, Luce J, et al. Improved survival with highly active antiretroviral therapy in HIV infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003;17:73-80.
23. Moyle G. Mitochondrial toxicity: myths and facts. HIV Ther 2004;9:45-47.
24. Granados JMS, Amador JTR, De Miguel SF, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003;22:863-7.
25. de Martino M, Balducci M, Galli L, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV infection in Children and the Italian National AIDS Registry. JAMA 2000;284:190-7.
26. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-8.
27. Fauci AS. The AIDS epidemic. Considerations for the 21st century. N Engl J Med 1999;341:1046-50.